BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20472532)

  • 21. The outcome of ELBW infants treated with NCPAP and InSurE in a resource-limited institution.
    Kirsten GF; Kirsten CL; Henning PA; Smith J; Holgate SL; Bekker A; Kali GT; Harvey J
    Pediatrics; 2012 Apr; 129(4):e952-9. PubMed ID: 22430447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentle ventilation: the new evidence from the SUPPORT, COIN, VON, CURPAP, Colombian Network, and Neocosur Network trials.
    Carlo WA
    Early Hum Dev; 2012 May; 88 Suppl 2():S81-3. PubMed ID: 22633522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the Vermont Oxford Neonatal Network.
    Kirchner L; Weninger M; Unterasinger L; Birnbacher R; Hayde M; Krepler R; Pollak A
    J Perinat Med; 2005; 33(1):60-6. PubMed ID: 15841616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?
    Aly H; Milner JD; Patel K; El-Mohandes AA
    Pediatrics; 2004 Sep; 114(3):697-702. PubMed ID: 15342841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bronchopulmonary dysplasia].
    Clément A
    Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants?
    Kribs A
    J Perinatol; 2009 Mar; 29(3):256. PubMed ID: 19240733
    [No Abstract]   [Full Text] [Related]  

  • 29. Airway obstruction during mask ventilation of very low birth weight infants during neonatal resuscitation.
    Finer NN; Rich W; Wang C; Leone T
    Pediatrics; 2009 Mar; 123(3):865-9. PubMed ID: 19255015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of atypical chronic lung disease in extremely low birth weight infants.
    Streubel AH; Donohue PK; Aucott SW
    J Perinatol; 2008 Feb; 28(2):141-8. PubMed ID: 18059466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous positive airway pressure and surfactant.
    Bohlin K; Jonsson B; Gustafsson AS; Blennow M
    Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of nasal injuries secondary to NCPAP application in the ELBW infant.
    Squires AJ; Hyndman M
    Neonatal Netw; 2009; 28(1):13-27. PubMed ID: 19176303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variables associated with the early failure of nasal CPAP in very low birth weight infants.
    Ammari A; Suri M; Milisavljevic V; Sahni R; Bateman D; Sanocka U; Ruzal-Shapiro C; Wung JT; Polin RA
    J Pediatr; 2005 Sep; 147(3):341-7. PubMed ID: 16182673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The combined effect of prenatal steroid prophylaxis, neonatal surfactant therapy and reduction of risk of complications from respiratory life support on survival rate of very low birthweight infants].
    Görbe E; Jeager J; Kohalmi B; Patkós P; Cziniel M; Sassi L
    Orv Hetil; 2004 Jun; 145(23):1227-32. PubMed ID: 15264590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early surfactant in spontaneously breathing with nCPAP in ELBW infants--a single centre four year experience.
    Kribs A; Vierzig A; Hünseler C; Eifinger F; Welzing L; Stützer H; Roth B
    Acta Paediatr; 2008 Mar; 97(3):293-8. PubMed ID: 18298776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lung disease of the very low birth weight infant--is it preventable?
    Ogawa Y
    Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myth: mechanical ventilation is a therapeutic relic.
    Gupta S; Sinha SK; Donn SM
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):275-8. PubMed ID: 21621495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.